Tumor necrosis factor alpha gene -376 polymorphism and susceptibility to multiple sclerosis: An Egyptian study

Journal of Neuroimmune Pharmacology

Volumn 6, Issue 1, 2011, Pages 142-147

  Nada, Mona Abd El Fattah ^b   Labib, Dalia Ahmed ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE

Author keywords

multiple sclerosis (MS); primary progressive multiple sclerosis (PPMS); remitting relapsing multiple sclerosis; tumor necrosis factor alpha (TNF ) gene polymorphism

Indexed keywords

GENOMIC DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DNA POLYMORPHISM; EGYPT; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CASE-CONTROL STUDIES; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79251633193     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-010-9220-0     Document Type: Article

References (33)

1. F Barkhof M Filippi JH van Waesberghe A Campi DH Miller HJ Adèr 1999 Interobserver agreement for diagnostic MRI criteria in suspected multiple sclerosis Neuroradiology 41 5 347 350 1:STN:280:DyaK1Mzgs1alsg%3D%3D 10.1007/s002340050762 10379592 (Pubitemid 29237714)
2. EC Beattie D Stellwagen W Morishita JC Bresnahan BK Ha M Von Zastrow MS Beattie RC Malenka 2002 Control of synaptic strength by glial TNF alpha Science 295 2282 2285 1:CAS:528:DC%2BD38XitlKls7Y%3D 10.1126/science.1067859 11910117 (Pubitemid 34258846)
3. TD Bird GP Jarvik NW Wood 2001 Genetic association studies: genes in search of diseases Neurology 57 1153 1154 1:STN:280:DC%2BD3MrksVyisA%3D%3D 11591829
4. BA De Jong TWJ Huizinga E Zanelli MJ Giphart EL Bollen BM Uitdehaag CH Polman RGJ Westendorp 2002 Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region Neurology 59 549 555 10.1001/archneur.59. 4.549 12196647
5. JA Fernandes Filho CA Vedeler KM Myhr H Nyland JP Pandey 2002 TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene Autoimmunity 35 377 380 10.1080/0891693021000021549 12568117 (Pubitemid 35252228)
6. M Fernandez-Arquero R Arroyo A Rubio C Martin P Vigi L Conejero MA Figueredo EG de la Concha 1999 Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis Neurology 53 1361 1363 1:CAS:528:DyaK1MXntVWhtrw%3D 10522904
7. JL Haines HA Terwedow K Burgess MA Pericak-Vance JB Rimmler ER Martin JR Oksenberg R Lincoln DY Zhang DR Banatao N Gatto DE Goodkin SL Hauser 1998 Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Multiple Sclerosis Genetics Group Hum Mol Genet 7 1229 1234 1:CAS:528:DyaK1cXltV2qtr4%3D 10.1093/hmg/7.8.1229 9668163
8. SL Hauser 1995 Tumor necrosis factor: immunogenetics and disease Ann Neurol 38 702 704 1:CAS:528:DyaK28XlsVWhtw%3D%3D 10.1002/ana.410380503 7486860
9. B He V Navikas J Lundahl M Söderström J Hillert 1995 Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis J Neuroimmunol 63 143 147 1:CAS:528:DyaK2MXhtVSgt7fF 10.1016/0165-5728(95)00138-7 8550811 (Pubitemid 26020718)
10. FM Hofman DR Hinton K Johnson JE Merrill 1989 Tumor necrosis factor identified in multiple sclerosis brain J Exp Med 170 607 612 1:CAS:528:DyaL1MXltlahsLY%3D 10.1084/jem.170.2.607 2754393
11. TW Huizinga RG Westendorp EL Bollen V Keijsers BM Brinkman JA Langermans FC Breedveld CL Verweij L van de Gaer L Dams JB Crusius A García-Gonzalez BW van Oosten CH Polman AS Peña 1997 TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients J Neuroimmunol 72 149 153 1:CAS:528:DyaK2sXhslanug%3D%3D 10.1016/S0165-5728(96)00182-8 9042107 (Pubitemid 27062770)
12. E Kamali-Sarvestani A Nikseresht E Aflaki J Sarvari B Gharesi-Fard 2007 TNF-alpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis Acta Neurol Scand 115 161 166 1:CAS:528:DC%2BD2sXjsFSms7g%3D 10.1111/j.1600-0404.2006.00743.x 17295710 (Pubitemid 46219208)
13. MA Kauffman DG Morón G Sandoval RE Sica O Garcea AM Villa 2007 Is tumor necrosis factor-376A promoter polymorphism associated with susceptibility to multiple sclerosis? Medicina 67 5 436 438 1:CAS:528:DC%2BD1cXit12gsrc%3D 18051225
14. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237
15. H Lassmann W Brück CF Lucchinetti 2007 The immunopathology of multiple sclerosis: an overview Brain Pathol 17 210 218 10.1111/j.1750-3639. 2007.00064.x 17388952 (Pubitemid 46466140)
16. E Losonczi K Bencsik ZF Nagy V Honti E Szalczer C Rajda Z Illés K Mátyás C Rózsa T Csépány J Füvesi L Vécsei 2009 Tumour necrosis factor alpha gene (TNF- α) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis J Neuroimmunol 208 115 118 1:CAS:528:DC%2BD1MXjsV2mtbk%3D 10.1016/j.jneuroim. 2009.01.004 19201038
17. G Lucotte C Bathelier G Mercier 2000 TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients Mult Scler 6 78 80 1:CAS:528:DC%2BD3cXjtFWqsrw%3D 10773851
18. D Maimone S Gregory BGW Arnason AT Reder 1991 Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis J Neuroimmunol 32 67 74 1:STN:280:DyaK3M7mtFKqsg%3D%3D 10.1016/0165-5728(91)90073-G 2002092
19. A Martínez A Rubio E Urcelay M Fernández-Arquero V de las Heras R Arroyo P Villoslada X Montalbán EG de la Concha 2004 TNF-376A marks susceptibility to MS in the Spanish population Neurology 62 809 810 15007139
20. WI McDonald A Compston G Edan D Goodkin HP Hartung FD Lublin HF McFarland DW Paty CH Polman SC Reingold M Sandberg-Wollheim W Sibley A Thompson S van den Noort BY Weinshenker JS Wolinsky 2001 Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 50 121 127 1:STN:280:DC%2BD38%2FitFOhug%3D%3D 10.1002/ana.1032 11456302 (Pubitemid 32591472)
21. S Mihailova M Ivanova A Mihaylova L Quin O Mikova E Naumova 2005 Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients J Neuroimmunol 168 138 143 1:CAS:528:DC%2BD2MXhtVynt7nN 10.1016/j.jneuroim.2005.06.020 16183136 (Pubitemid 41396411)
22. M Mycko W Kowalski M Kwinkowski AC Buenafe B Szymanska E Tronczynska A Plucienniczak K Selmaj 1998 Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin alpha J Neuroimmunol 84 198 206 1:CAS:528:DyaK1cXitlSqs7w%3D 10.1016/S0165-5728(97)00255-5 9628463 (Pubitemid 28248406)
23. M Pickering D Cumiskey JJ O'Connor 2005 Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system Exp Physiol 90 663 670 1:CAS:528:DC%2BD2MXhtFKkt7%2FM 10.1113/expphysiol.2005.030734 15944202 (Pubitemid 41406053)
24. CH Polman SC Reingold G Edan M Filippi HP Hartung L Kappos FD Lublin LM Metz HF McFarland PW O'Connor M Sandberg-Wollheim AJ Thompson BG Weinshenker JS Wolinsky 2005 Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58 840 846 10.1002/ana.20703 16283615 (Pubitemid 41746873)
25. P Rieckmann M Albrecht B Kitze T Weber H Tumani A Broocks W Luer S Poser 1994 Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis Neurology 44 1523 1:STN:280:DyaK2czjs1Sgtg%3D%3D 8058164
26. P Rieckmann M Albrecht B Kitze T Weber H Tumani A Broocks W Luer A Helwig S Poser 1995 Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity Ann Neurol 37 82 88 1:STN:280:DyaK2M7hvVSnsA%3D%3D 10.1002/ana.410370115 7818262
27. JD Sedgwick DS Riminton JG Cyster H Korner 2000 Tumor necrosis factor: a master-regulator of leukocyte movement Immunol Today 21 110 113 1:CAS:528:DC%2BD3cXhsFOjurg%3D 10.1016/S0167-5699(99)01573-X 10689296 (Pubitemid 30122696)
28. MK Sharief R Hentges 1991 Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis N Engl J Med 325 467 472 1:STN:280:DyaK3MzgsVGgsg%3D%3D 10.1056/NEJM199108153250704 1852181
29. Tansey MG, Wyss-Coray T (2008) Cytokines in CNS inflammation and disease. In: Lane TE, Carson M (eds) Central nervous system diseases and inflammation. Springer
30. BG Weinshenker DM Wingerchuk Q Liu AS Bissonet DJ Schaid SS Sommer 1997 Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis Neurology 49 378 385 1:CAS:528:DyaK2sXmtVGisb4%3D 9270565 (Pubitemid 27368870)
31. BG Weinshenker DD Hebrink E Atkinson OH Kantarci 2001 Association of a tumor necrosis factor alpha polymorphism with MS susceptibility Neurology 57 1341 1342 1:STN:280:DC%2BD3MrksVyntw%3D%3D 11591866
32. DM Wingerchuk Q Liu J Sobell S Sommer BG Weinshenker 1997 A population-based case-control study of the tumor necrosis factor alpha -308 polymorphism in multiple sclerosis Neurology 49 626 628 1:STN:280: DyaK2svhs1Kltg%3D%3D 9270614 (Pubitemid 27368919)
33. SA Wirz MC Morale B Marchetti AM Barr S Sotgiu G Rosati M Pugliatti MV Sanna O Giliberto T Bartfai B Conti 2004 High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia Cytokine 26 149 154 1:CAS:528:DC%2BD2cXktVKhu74%3D 10.1016/j.cyto.2004.02.006 15149631 (Pubitemid 38624627)